Q32 Bio (Q32 Bio) Research & Development : $18.18 Mil (TTM As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Q32 Bio Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Q32 Bio's Research & Development for the three months ended in Mar. 2024 was $9.84 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $18.18 Mil.

Q32 Bio Research & Development Historical Data

The historical data trend for Q32 Bio's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q32 Bio Research & Development Chart

Q32 Bio Annual Data

Trend

Dec21

Dec22

Dec23

Research & Development

29.93

35.81

31.73

Q32 Bio Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial			9.19	7.91	-	8.34	9.84

Q32 Bio Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $18.18 Mil.

Q32 Bio (NAS:QTTB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Q32 Bio Research & Development Related Terms

Thank you for viewing the detailed overview of Q32 Bio's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Q32 Bio (Q32 Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q32 Bio Inc (NAS:QTTB) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

830 Winter Street, Waltham, MA, USA, 02451

Website

https://www.q32bio.com

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Q32 Bio (Q32 Bio) Headlines

From GuruFocus

Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer

By PRNewswire • 04-03-2024